Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50.

导出 OA

翻译打印收藏纠错

作者： E,Pons-Tostivint ^[1] ; P,Hulo ^[2] ; V,Guardiolle ^[3] ; L,Bodot ^[4] ; A,Rabeau ^[4] ; M,Porte ^[5] ; S,Hiret ^[5] ; P,Demontrond ^[6] ; H,Curcio ^[6] ; A,Boudoussier ^[7] ; R,Veillon ^[7] ; M,Mayenga ^[8] ; C,Dumenil ^[9] ; T,Chatellier ^[2] ; P A,Gourraud ^[3] ; J,Mazieres ^[4] ; J,Bennouna ^[8]

作者单位： Centre Hospitalier Universitaire Nantes, Medical Oncology, Nantes University, 44000, Nantes, France. elvire.pons@chu-nantes.fr. ^[1] Medical Oncology Unit, Clinique Mutualiste de L'Estuaire, Saint-Nazaire, France. ^[2] Centre Hospitalier Universitaire Nantes, Institute of Health and Medical Research, Santé Publique, Clinique Des Données, Inserm CIC 1413, Centre Hospitalier Universitaire de Nantes, Nantes University, 44000, Nantes, France. ^[3] Thoracic Oncology Department, Hôpital Larrey, CHU Toulouse, 31000, Toulouse, France. ^[4] Department of Medical Oncology, Comprehensive Cancer Center, Institut de Cancérologie de L'Ouest, Saint-Herblain, France. ^[5] Department of Pneumology, Centre François Baclesse, Caen, France. ^[6] Department of Pneumology, University Hospital of Bordeaux, Pessac, France. ^[7] Department of Medical Oncology, Hospital Foch, Suresnes, France. ^[8] Department of Respiratory Diseases and Thoracic Oncology, APHP-Hopital Ambroise Pare, 92100, Boulogne-Billancourt, France. ^[9]

关键词 Chemo-immunotherapy First-line Immunotherapy Non-small cell lung cancer

主题词人类(Humans);男(雄)性(Male);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);铂(Platinum);回顾性研究(Retrospective Studies)

DOI 10.1007/s00262-022-03359-2

PMID 36690799

发布时间 2023-05-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交